A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616].

Hogg, Ronald J; Wyatt, Robert J

Hogg, Ronald J; Wyatt, Robert J.

Affiliation

Hogg RJ; Department of Pediatrics, Medical City Dallas Hospital, Dallas, TX, USA. spnsg@lonestarhealth.com

BMC Nephrol ; 5: 3, 2004 Mar 25.

Article in En | MEDLINE | ID: mdl-15043759

Subject(s)

Glomerulonephritis, IGA/drug therapy; Immunosuppressive Agents/therapeutic use; Mycophenolic Acid/analogs & derivatives; Mycophenolic Acid/therapeutic use; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Docosahexaenoic Acids/therapeutic use; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid/therapeutic use; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA/complications; Humans; Lisinopril/therapeutic use; Male; Proteinuria/drug therapy; Proteinuria/etiology; Research Design; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, IGA / Immunosuppressive Agents / Mycophenolic Acid Type of study: Clinical_trials / Etiology_studies Limits: Female / Humans / Male Language: En Journal: BMC Nephrol Journal subject: NEFROLOGIA Year: 2004 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google